GlassScriptPhysician profile
Bradford Kleinman
NPI 1093702391
$2,348.65
in general payments reported to CMS, 2019-2025
28 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $267 · 2021: $507 · 2022: $420 · 2023: $340 · 2024: $154 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $450.62 | 2019-2023 | |
| Exeltis, USA INC. | $261.54 | 2019-2024 | Slynd |
| Renovia INC | $242.56 | 2019-2021 | |
| Amgen INC. | $197.79 | 2020-2025 | Evenity, Prolia, Prolia |
| Aspira Women'S Health INC | $192.46 | 2021-2023 | Ova1 |
| Pfizer INC. | $146.57 | 2019-2025 | |
| Therapeuticsmd, INC. | $136.61 | 2019 | |
| Astellas Pharma US INC | $98.03 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $71.14 | 2019-2023 | Summit Doppler |
| Daiichi Sankyo INC. | $70.65 | 2020-2021 | |
| Exact Sciences Corporation | $59.32 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $57.43 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $50.21 | 2021-2025 | |
| Hologic Sales and Service, LLC | $35.34 | 2022-2025 | Myosure Tissue Removal Device |
| Axonics, INC. | $35.30 | 2023 | Axonics |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $30.58 | 2021-2022 | |
| Millicent US INC | $29.20 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $24.69 | 2023 | |
| Merck Sharp & Dohme LLC | $21.49 | 2023 | Gardasil 9 |
| Glaxosmithkline, LLC. | $20.68 | 2022 | |
| Scynexis, INC. | $19.72 | 2022 | |
| Sumitomo Pharma America, INC. | $17.25 | 2023 | Myfembree |
| Organon LLC | $17.14 | 2025 | Nexplanon |
| Seqirus USA INC | $14.14 | 2024 | Fluad, Flucelvax |
| Vertical Pharmaceuticals, LLC | $12.42 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.34 | 2021 | |
| Evofem Biosciences, INC. | $11.78 | 2022 | |
| Allergan, INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradford Kleinman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.